NCT03008954View on ClinicalTrials.gov

Effect of GSP3 on Body Weight in Overweight and Obese Subjects

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
OverweightObesity
Interventions
DEVICE

GSP3

Each capsule of GSP3 (previously Attiva) contains 700 mg of a mixture of two food-grade materials: carboxymethylcellulose that is cross-linked with citric acid.

DIETARY_SUPPLEMENT

Avicel (modified Cellulose)

Each capsule of Avicel contains approximately 350 mg of microcrystalline cellulose

Trial Locations (5)

80131

Federico University Hospital, Naples

500 00

Hradec Králové, Hradec

121 08

Charles University, Prague

DK-1958

University of Cophenhagen, Copenhagen

00161

Policlinico Umberto I, Rome

Sponsors

Lead Sponsor

Gelesis, Inc.
All Listed Sponsors
lead

Gelesis, Inc.

INDUSTRY

NCT03008954 - Effect of GSP3 on Body Weight in Overweight and Obese Subjects | Biotech Hunter | Biotech Hunter